CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...
Phase 2
Charlotte, North Carolina, United States and 7 other locations
The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...
Phase 2
Charlotte, North Carolina, United States and 3 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 104 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Charlotte, North Carolina, United States and 215 other locations
with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 7 other locations
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...
Phase 1
Huntersville, North Carolina, United States of America and 13 other locations
pharmacokinetic profile of GRC54276 alone and in combination with pembrolizumab or atezolizumab in participants with advanced solid tumors and lymphomas...
Phase 1
Huntersville, North Carolina, United States of America and 17 other locations
in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...
Phase 3
Charlotte, North Carolina, United States and 134 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Charlotte, North Carolina, United States and 58 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Charlotte, North Carolina, United States and 194 other locations
Clinical trials
Research sites
Resources
Legal